Evidence map›Paper›PMID 34462573›Full record

ArticleMucosal immunology2021

Correction to: Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion.

Wayne T Muraoka, Anna A Korchagina, Qingqing Xia, Sergey A Shein, Xi Jing, Zhao Lai, Korri S Weldon, Li-Ju Wang, Yidong Chen, Lawrence W Kummer and 4 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Mucosal immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Wayne T Muraoka *Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, USA.
Anna A Korchagina *Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, USA.
Qingqing XiaTrudeau Institute, Saranac Lake, NY, USA.
Sergey A SheinDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, USA.
Xi JingDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, USA.
Zhao LaiGreehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA.
Korri S WeldonGreehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA.
Li-Ju WangGreehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA.
Yidong ChenGreehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX, USA.
Lawrence W KummerTrudeau Institute, Saranac Lake, NY, USA.
Markus MohrsTrudeau Institute, Saranac Lake, NY, USA.
Eric VivierInnate Pharma Research Laboratories, Innate Pharma, CNRS, INSERM, CIML, and Assistance Publique des Hôpitaux de Marseille, Hôpital de la Timone, Immunology, Marseille-Immunopôle, Aix Marseille University, Marseille, France.
Ekaterina P KorolevaDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, USA.
Alexei V TumanovDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, USA. tumanov@uthscsa.edu.ORCID http://orcid.org/0000-0001-6042-0152

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34462573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.